<\/p>\n
NEW FILINGS<\/strong><\/p>\n Company: Pliant Therapeutics, Inc. Company: Dada Nexus Limited Company: Legend Biotech Corporation Company: Calliditas Therapeutics AB TERMS ADDED<\/strong><\/p>\n Company: SelectQuote, Inc.
\nSymbol: PLRX
\nDescription: They are a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Our initial focus is on treating fibrosis by inhibiting integrin-mediated activation of TGF-\u00df.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Cowen, Piper Sandler
\nCo-Manager(s): Needham & Co.
\nFiled: 5-11-20
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: DADA
\nDescription: We are a leading platform of local on-demand retail and delivery in China. We operate JD-Daojia (\u201cJDDJ\u201d), one of China\u2019s largest local on-demand retail platforms by GMV in 2019, and Dada Now, a leading local on-demand delivery platform in China by number of orders in 2019, according to the iResearch Report.
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, BofA Securities, Jefferies
\nFiled: 5-12-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: LEGN
\nDescription: They are a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, JP Morgan, Jefferies
\nFiled: 5-13-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: CALT
\nDescription: They are a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. Their common shares are traded on Nasdaq Stockholm under the symbol \u201cCALTX.\u201d
\nShares: TBD
\nPrice Range: TBD
\nMarket Cap: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Jefferies, Stifel
\nCo-Manager(s): Carnegie
\nFiled: 5-14-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: SLQT
\nDescription: They are united by their mission to provide solutions that help consumers with their overall financial well-being and protect their most valued assets: their families, their health and their property.
\nShares: 25 million
\nPrice Range: $17.00-$19.00
\nTrade Date: Friday, 5\/22
\nMarket Cap: $2.8b-$3.1b
\nUnderwriter(s): Credit Suisse, Morgan Stanley, Evercore ISI, RBC Capital Markets, Barclays, Citigroup, Jefferies
\nCo-Manager(s): Cantor, Keefe Bruyette & Woods, Piper Sandler, Drexel Hamilton
\nTerms Added: 5-15-20<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-12577","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/12577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=12577"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/12577\/revisions"}],"predecessor-version":[{"id":12580,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/12577\/revisions\/12580"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=12577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=12577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=12577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}